Verbal and visual memory in patients with early Parkinson's disease: Effect of levodopa

Neurology India

Volumn 54, Issue 1, 2006, Pages 33-37

  Singh, Sumit ^a   Behari, Madhuri ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Benton; Form; Levodopa; Memory; Parkinson's; Rey's

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BENTON VISUAL RETENTION TEST; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DEPRESSION; DISEASE DURATION; DRUG EFFECT; FEMALE; FORM SEQUENCE LEARNING TEST; HAMILTON SCALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PROSPECTIVE STUDY; REY AUDITORY VERBAL LEARNING TEST; VERBAL MEMORY; VISUAL MEMORY;

EID: 33646747030     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: 10.4103/0028-3886.24699     Document Type: Article

References (20)

1. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated, Parkinson's disease and its relationship to motor disability. Brain 1991;114:2095-122.
2. Starkstien ES, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective long term study of depression, cognitive deficits and physical impairment in patients of Parkinson's disease. J. Neurol Neurosurg Psychiatr 1992;55:377-82.
3. Brown Ra, Marsden CD. Cognitive functions in Parkinson's disease: from description to Theory [Review]. Trends Neurosci 1990;13:21-9.
4. Maeyux R, Stern Y, Rosentein R, Marder K, Hauser A, Cote L, et al. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch Neurol 1988;45:260-2.
5. Warburton JW. Memory disturbance and the Parkinson syndrome. Br J Med Psychol 1967;40:169-71.
6. Poewe W, Berger W, Benke T, Scheolsky L. High speed memory scanning in Parkinson's disease:adverse effects of levodopa. Ann Neurol 1991;29:670-3.
7. Morrison CE, Borod JC, Brin MF, Halbig TD, Olanow CW. Effects of levodopa on cognitive functioning in moderate to severe Parkinson's disease. J Neural Transm 2004;111:1333-41.
8. Chaudhary SK, Sheshadri S, Behari M, Prasad K, (Abs). Hindi version of the Folstein's Mini Mental Scale Examination. International conference of Alzheimer's disease: Cochin Kerala India.
9. van der Elast W, van Boxtel MP, van Breukelen GJ, Jolles J. Reys verbal learning test:normative data for 1855 healthy participants aged 24-81 years and the influence of age sex education and the mode of presentation. J Int Neuropsychol Soc 2005;11:290-302.
10. Hamsher KS, Roberts RJ, Benton AL, Form sequence learning test-Manual of instructions (rev. ed.) University of Wisconsin Med School: Milwaukee WI; 1980.
11. rd edn. Oxford University Press: New York; 1995.
12. Bedard MA, Pillon B, Dubois B, Duchesne N, Masson H, Agid Y. Acute and long term administration of anticholinergics in Parkinson's disease: specific effects on the Subcorticofrontal syndrome. Brain Cogn 1999;40.2:289-313.
13. Dixit SN, Behari M, Ahuja GK. Effect of selegiline on cognitive functions in Parkinson's disease. J Assoc Physics India 1999;47:784-6.
14. Jacobs D, Marder K, Cote LJ, Sano M, Stern Y, Mayeux R. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology 1995;45:1691-6.
15. Kulisewsky J, Garcia-Sanchez C, Berthier ML, Barbanoj M, Pascual-Sedano B. et al. Chronic effects of Dopaminergic replacement on Cognitive functions in Parkinson's disease: a two year follow up study of previously untreated patients. Mov Disorders 2000;15:613-26.
16. Kulisevsky J, Avila A, Barbanoj M, Antonijoan R, Berthier ML, Gironell A. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels. Brain 1996;119:2121-32.
17. Cooper JA, Sagar HJ, Sullivan EV. Short term memory and temporal sequencing in Early Parkinson's Disease: the effect of disease chronicity and medication. Neoropsychologia 1993;31.9:933-49.
18. Williams GV, Goldman-Rakic PS. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995;376:572-5.
19. Frank MJ. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and non-medicated Parkinsonism. J Cogn Neurosci 2005;17:51-72.
20. Singh S, Sesadri S, Behari M. Frontal lobe functions in patients with Parkinson's disease-effect of levodopa. Mov Disord 2003;5:S278.